Transforming growth factor (TGF)-β mimics and anti-TGF-β antibody abrogates the in vivo effects of cyclosporine demonstration of a direct role of TGF-β in immunosuppression and nephrotoxicity of cyclosporine

Transplantation

Volumn 67, Issue 6, 1999, Pages 882-889

  Khanna, Ashwani K ^a   Cairns, Victor R ^a   Becker, Carl G ^a   Hosenpud, Jeffrey D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

EID: 0033608710     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903270-00016     Document Type: Article

References (67)

1. Shihab FS. Cyclosporine nephropathy: pathophysiology and clinical impact. Semin Nephrol 1996; 16: 536.
2. Falkenhain ME, Cosio FG, Sedmak DD. Progressive histologic injury in kidneys from heart and liver transplant recipients receiving Cyclosporine. Transplantation 1996; 62: 364.
3. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1.
4. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 1993; 8: 1.
5. Massagué J, Cheifetz S, Laiho M, Ralph DA, Weis FM, Zentella A. Transforming growth factor-beta. Cancer Surv 1992; 12: 81.
6. Kim S-J, Angel P, Lafyatis R, et al. Auto-induction of transforming growth factor-betal is mediated by the AP-1 complex. Mol Cell Biol 1990; 10: 1492.
7. Khanna AK, Li B, Stenzel KH, Suthanthiran M. Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth. Transplantation 1994; 57: 577.
8. 1 complementary DNA. Biochem Biophys Res Commun 1994; 204: 1061.
9. Khanna A, Kapur S, Sharma V, Li B, Suthanthiran M. In vivo hyperexpression of transforming growth factor-beta 1 in mice: stimulation by cyclosporine. Transplantation 1997; 63: 1037.
10. Khanna AK, Li B, Li P, Suthanthiran M. Transforming growth factor-beta 1: regulation with a TGF-beta 1 antisense oligomer. Kidney Int Suppl 1996; 53: S2.
11. Khanna A, Li B, Sharma VK, Suthanthiran M. Immunoregulatory and fibrogenic activities of cyclosporine: a unifying hypothesis based on transforming growth factor-β expression. Transplant Proc 1996; 28: 2015.
12. Khanna AK, Li B, Sehajpal PK, Sharma VK, Suthanthiran M. Mechanism of action of cyclosporine: a new hypothesis implicating transforming growth factor-β. Transplant Rev 1995; 9: 41.
13. ++ elevation and cyclosporin (CsA) synergistically induce transforming growth factor β1 (TGF-β1)-mediated apoptosis in mature lymphocytes. J Immunol 1997; 158: 2527.
14. Shin GT, Khanna A, Sharma V, et al. Heightened expression of transforming growth factor-β (TGF-β) following CsA monotherapy in humans. Transplant Proc 1997; 29: 284.
15. Prashar Y, Khanna A, Sehajpal P, Sharma VK, Suthanthiran M. Stimulation of TGF-β by cyclosporine. FEBS Lett 1995; 358: 109.
16. Li B, Sehajpal P, Khanna A, et al. Differential regulation of transforming growth factor β and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 1991; 174: 1259.
17. Wolf G, Thaiss F, Stahl RA. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells: possible mechanism of cyclosporine's antiproliferative effects. Transplantation 1995; 60: 237.
18. Ahuja SS, Shrivastav S, Danielpour D, Balow JE, Boumpas DT. Regulation of transforming growth factor-beta 1 and its receptors by cyclosporine in human T cells. Transplantation 1995; 60: 718.
19. Shehata M, Cope JH, Johonson TS, Raftery AT, el Nahas AM. Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells in the rat kidney. Kidney Int 1995; 48: 1487.
20. Shihab FS, Andoh TF, Tanner AM, et al. Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy. Kidney Int 1996; 49: 1141.
21. Pankewycz OG, Miao L, Isaacs R, et al. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney Int 1996; 50: 1634.
22. Mauck K, Khanna A, Hosenpud J. An evaluation of Ready-To-Go products for the study of differential expression of growth factors in human aortic endothelial cells. Science Tools 1997; 2: 8.
23. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1995; 316: 701.
24. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984; 12: 1687.
25. Kurkinen M, Condon R, Blumberg B, et al. Extensive homology between the carboxyl-terminal peptides of mouse alpha-1 (IV) and alpha-2(IV) collagen. J Biol Chem 1987; 262: 8496.
26. Talts JF, Weller A, Timpl R, Ekblom M, Ekblom P. Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma. J Cell Sci 1995; 108: 2153.
27. Wahl SM, Hunt DA, Bansal G, McCartney-Francis N, Elling-sworth L, Allen JB. Bacterial cell wall-induced immunosuppression: role of transforming growth factor beta. J Exp Med 1988; 168: 1403.
28. Brandes ME, Wakefield LM, Allen JB, Ogawa Y, Wahl SM. Transforming growth factor-beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991; 87: 1108.
29. Kuruvilla AP, Shah R, Hochwald GM, Liggit HD, Palladino MA, Thorbecke GJ. Protective effects of transforming growth factor-beta 1 on experimental autoimmune disease in mice. Proc Natl Acad Sci USA 1991; 88: 2918.
30. Santambrogio L, Hochwald GM, Saxena B, et al. Studies on the mechanism by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis: antagonism between TGF-beta and tumor necrosis factor. J Immunol 1993; 151: 1116.
31. Wallick SC, Figari IS, Morris RE, Levinson AD, Palladino MA. Immunoregulatory role of transforming growth factor-beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J Exp Med 1990; 172: 1777.
32. Qin L, Chavin KD, Ding Y, Favaro JP, Lin J, Bromberg JS. Gene transfer for transplantation: prolongation of allograft survival with transforming growth factor-beta 1. Ann Surg 1994; 220: 508.
33. Deng S, Ketchum RJ, Yang ZD, et al. IL-10 and TGF-beta gene transfer to rodent islets: effect on xenogeneic islet graft survival in naïve and B-cell deficient mice. Transplant Proc 1997; 29: 2207.
34. Nall AV, Brownlee RE, Colvin CP, et al. Transforming growth factor-beta 1 improves wound healing and random flap survival in normal and irradiated rats. Arch Otolaryngol Head Neck Surg 1996; 122: 171.
35. Raju GP, Belland SE, Eisen HJ. Prolongation of cardiac allograft survival with transforming growth factor-beta 1 in rats. Transplantation 1994; 58: 392.
36. Waltenberger J, Miyazono K, Funa K, Wanders A, Fellstrom B, Heldin CH. Transforming growth factor-beta and organ translantation. Transplant Proc 1993; 25: 2038.
37. Meert KL, Ofenstein JP, Geneyea C, Saranik AP, Kaplan J. Elevated transforming growth factor-beta concentration correlates with posttrauma immunosuppression. J Trauma 1996; 40: 901.
38. D'Angeac AD, Dornand J, Emonds-Alt X, Jullien P, Garcia-Sanz JA, Erard F. Transforming growth factor type beta 1 (TGF-beta 1) down-regulates interleukin-2 production and up-regulates interleukin-2 receptor expression in a thymoma cell line. J Cell Physiol 1991; 147: 460.
39. Stoeck M, Miescher S, MacDonald HR, Von Fliedner V. Transforming growth factor beta slows down cell-cycle progression in a murine interleukin-2 dependent T-cell line. J Cell Physiol 1989; 141: 65.
40. Kehrl JH, Wakefield LM, Roberts AB, et al. The production of TGF-β by human T lymphocytes and its potential role in regulation of T cell growth. J Exp Med 1986; 163: 1037.
41. Ruscetti F, Varesio L, Ochoa A, Ortaldo J. Pleiotropic effects of transforming growth factor-β on cells of the immune system. Ann N Y Acad Sci 1993; 685: 488.
42. Fontana A, Hengartner H, de Tribolet N, Weber E. Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2-mediated effects. J Immunol 1984; 132: 1837.
43. Brabletz T, Pfeuffer I, Schorr E, Siebelt F, Wirth T, Serfling E. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding domain. Mol Cell Biol 1993; 13: 1155.
44. Bright JJ, Kerr LD, Sriram S. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes. J Immunol 1997; 159: 175.
45. Dumont FJ, Kastner CA. Transforming growth factor β1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-γ production in a T cell lymphoma: comparison with the effects of rapamycin. J Cell Physiol 1994; 160: 141.
46. Espevik T, Figari IS, Shalaby MR, et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor-β. J Exp Med 1987; 166: 571.
47. Stoeck M, Howe RC, Miescher S, Von Fliedner V, MacDonald HR. Effect of transforming growth factor beta on the EL4 thymoma variant EL4/6.1: dissociation of inhibition of proliferation from expression of IL-1 and IL-2 receptors. Immunobiology 1990; 181: 13.
48. Holter W, Kalthoff FS, Pickl WF, et al. Transforming growth factor-beta inhibits IL-4 and IFN-gamma production by stimulated human T cells. Int Immunol 1994; 6: 469.
49. Reinhold D, Bank U, Buhling F, et al. Transforming growth factor-beta 1 (TGF-beta 1) inhibits DNA synthesis of PWM stimulated PBMC via suppression of IL-2 and IL-6 production. Cytokine 1994; 6: 382.
50. Fox FE, Capocasale RJ, Ford HC, Lamb RJ, Moore JS, Nowell PC. Transforming growth factor-beta inhibits human T-cell proliferation through multiple targets. Lymphokine Cytokine Res 1992; 11: 299.
51. Takeuchi M, Alard P, Streilein JW. TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells. J Immunol 1998; 160: 1589.
52. Geller RL, Smyth M, Strobl S, et al. Generation of lymphokine-activated killer activity in T cells: possible regulatory circuits. J Immunol 1991; 146: 3280.
53. Kuppner MC, Hamou MF, Bodmer S, Fontana A, de Tribolet N. The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer 1988; 42: 562.
54. Czarniecki CW, Chiu HH, Wong GHW, McCabe SM, Palladino MA. Transforming growth factor-β1 modulates the expression of class II histocompatability antigens on human cells. J Immunol 1988; 140: 4217.
55. Kehrl JH, Taylor AS, Delsing GA, Roberts AB, Sporon MB. Further studies of the role of transforming growth factor-β in human B cell function. J Immunol 1989; 143: 1868.
56. Yamashita W, MacCarthy EP, Hsu A, Gartside PS, Ooi BS. The effect of transforming growth factor-β on mouse mesangial cell proliferation. Clin Exp Immunol 1989; 77: 285.
57. Kehrl JH, Thevenin C, Reickmann P, Fauci AS. Transforming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J Immunol 1991; 146: 4016.
58. Batiuk TD, Pazderka F, Enns J, De Castro L, Halloran PF. Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium. Transplantation 1996; 61: 158.
59. Quien RM, Kaiser BA, Dunn SP, et al. Calcineurin activity in children with renal transplants receiving cyclosporine. Transplantation 1997; 64: 1486.
60. Zhang BW, Zimmer G, Chen J, et al. T cell responses in calcineurin A alpha-deficient mice. J Exp Med 1996; 183: 413.
61. Kung L, Halloran PF. Mechanism of action of cyclosporine A (CsA) and tacrolimus (FK) on calcineurin (CN) [Abstract]. Transplantation 1998; 65: 104.
62. Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337.
63. Yamamoto T, Noble NA, Miller DE, Border WA. Sustained expression TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916.
64. Isaka Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993; 92: 2597.
65. Terrel TG, Working PK, Chow CP, Green JD. Pathology of recombinant human transforming growth factor-β1 in rats and rabbits. Int Rev Exp Pathol 1993; 34: 43.
66. Kopp JB, Factor VM, Mozes M, et al. Transgenic mice with increased plasma levels of TGF-β 1 develop progressive renal disease. Lab Invest 1996; 74: 991.
67. Razzaque MS, Harada T, Taguchi T. Significance of increased accumulation of type VI collagen and transforming growth factor beta 1 in tubulointerstitial damage in hypertensive nephrosclerosis: an immunohistochemical study. J Int Med Res 1996; 64: 199.